WANSF yields 1111.11% · PFE yields 6.13%● Live data
📍 WANSF pulled ahead of the other in Year 1
Combined, WANSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WANSF + PFE for your $10,000?
Cirata plc, together with its subsidiaries, engages in the development and provision of collaboration software in North America, Europe, China, and internationally. The company's WANdisco Data Activation Platform offers Data Migrator, an automated cloud migration solution that migrates HDFS data and Hive metadata to the cloud; Data Migrator for Azure, a native Azure service that enables users to migrate petabyte-scale Hadoop data and Hive metadata to the Azure cloud; and Edge to Cloud, a tool designed to move IoT and file data across edge systems, data centers, and public clouds to enable organizations to activate their data for AI, machine learning, and advanced analytics on modern cloud data platforms. Its application lifecycle management products include Subversion MultiSite Plus, Git MultiSite, Gerrit MultiSite, and Access Control Plus, as well as offers data migration services. The company was formerly known as WANdisco plc and changed its name to Cirata plc in October 2023. Cirata plc was founded in 2005 and is based in St. Helier, Jersey.
Full WANSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.